Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Details)

v3.22.1
Net Loss Per Share (Details) - shares
shares in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Amount of weighted-average anti-dilutive common shares 6,419 1,118
Warrant    
Amount of weighted-average anti-dilutive common shares 5,442 719
Employee Stock Option    
Amount of weighted-average anti-dilutive common shares 977 399